Heme oxygenase-1 dysregulation in the brain: Implications for hivassociated neurocognitive disorders

Current HIV Research

Volumn 12, Issue 3, 2014, Pages 174-188

  Ambegaokar, Surendra S ^a   Kolson, Dennis L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Dimethyl fumarate; Heme oxygenase; Hiv associated neurocognitive disorders; Ho 1; Neuroinflammation; Oxidative stress

Indexed keywords

CURCUMIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; FUMARIC ACID DIMETHYL ESTER; FUMARIC ACID METHYL ESTER; GLUTAMIC ACID; HEME; HEME OXYGENASE 1; HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 1BETA; NEUROTOXIN; OMEGA 3 FATTY ACID; PROTOPORPHYRIN COBALT; TUMOR NECROSIS FACTOR ALPHA; GLUTAMIC ACID DERIVATIVE;

ARTICLE; BACTERIAL INFECTION; CD11+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL SURVIVAL; CYCLIC AMP RESPONSIVE ELEMENT; CYTOKINE PRODUCTION; DEGENERATIVE DISEASE; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; METABOLISM; MICROGLIA; NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; NEUROPROTECTION; OXIDATIVE STRESS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VIRUS REPLICATION; BIOSYNTHESIS; BRAIN; DOWN REGULATION; ENZYMOLOGY; GENE EXPRESSION REGULATION; PATHOLOGY; PATHOPHYSIOLOGY; VIROLOGY;

AIDS DEMENTIA COMPLEX; BRAIN; DOWN-REGULATION; GENE EXPRESSION REGULATION; GLUTAMATES; HEME OXYGENASE-1; HUMANS; MACROPHAGES;

EID: 84906256686     PISSN: 1570162X     EISSN: 18734251     Source Type: Journal    
DOI: 10.2174/1570162X12666140526122709     Document Type: Article

References (312)

1. Perl A, Banki K. Genetic and metabolic control of the mitochondrial transmembrane potential and reactive oxygen intermediate production in HIV disease. Antioxidants and Redox Signaling 2000; 2(3): 551-73.
2. Elbim C, Pillet S, Prevost MH, Preira A, Girard PM. The role of phagocytes in HIV-related oxidative stress. Journal of Clinical Virology 2001; 20(3): 99-109.
3. Allard JP, Aghdassi E, Chau J, Salit I. Oxidative stress and plasma antioxidant micronutrients in humans with HIV infection. American Journal of Clinical Nutrition 1998; 67(1): 143-7.
4. Repetto M, Reides C, Carretero MG, Costa M. Oxidative stress in blood of HIV infected patients. Clinica Chimica Acta 1996; 255(2): 107-17.
5. Valcour V, Shiramizu B. HIV-associated dementia, mitochondrial dysfunction, and oxidative stress. Mitochondrion 2004; 4(2-3): 119-29.
6. Mollace V, Nottet HS, Clayette P, et al. Oxidative stress and neuroAIDS: triggers, modulators and novel antioxidants. Trends in Neurosciences 2001; 24(7): 411-6.
7. Aukrust P, Svardal AM, Müller F, Lunden B, Berge RK, Frøland SS. Decreased levels of total and reduced glutathione in CD4+ lymphocytes in common variable immunodeficiency are associated with activation of the tumor necrosis factor system: possible immunopathogenic role of oxidative stress. Blood 1995; 86(4): 1383-91.
8. Ronaldson PT, Bendayan R. HIV-1viral envelope glycoprotein gp120 produces oxidative stress and regulates the functional expression of multidrug resistance protein-1 (Mrp1) in glial cells. Journal of Neurochemistry 2008; 106(3): 1298-313.
9. Turchan-Cholewo J, Dimayuga FO, Gupta S, et al. Morphine and HIV-Tat increase microglial-free radical production and oxidative stress: possible role in cytokine regulation. Journal of Neurochemistry 2009; 108(1): 202-15.
10. Deshmane SL, Mukerjee R, Fan S, et al. Activation of the oxidative stress pathway by HIV-1 Vpr leads to induction of hypoxia-inducible factor 1alpha expression. Journal of Biological Chemistry 2009; 284(17): 11364-73.
11. Eck HP, Gmünder H, Hartmann M, Petzoldt D, Daniel V, Dröge W. Low concentrations of acid-soluble thiol (cysteine) in the blood plasma of HIV-1-infected patients. Biological Chemistry 1989; 370(2): 101-8.
12. de Quay B, Malinverni R, Lauterburg BH. Glutathione depletion in HIV-infected patients: role of cysteine deficiency and effect of oral N-acetylcysteine. AIDS 1992; 6(8): 815-9.
13. Malvy DJ, Richard MJ, Arnaud J, Favier A, Amedee-Manesme O. Relationship of plasma malondialdehyde, vitamin E and antioxidant micronutrients to human immunodeficiency virus-1 seropositivity. Clinica Chimica Acta 1994; 224(1): 89-94.
14. Sönnerborg A, Carlin G, Akerlund B, Jarstrand C. Increased production of malondialdehyde in patients with HIV infection. Scandinavian Journal of Infectious Diseases 1988; 20(3): 287-90.
15. Revillard JP, Vincent CM, Favier AE, Richard MJ, Zittoun M, Kazatchkine MD. Lipid peroxidation in human immunodeficiency virus infection. Journal of Acquired Immune Deficiency Syndromes 1992; 5(6): 637-8.
16. McLemore JL, Beeley P, Thorton K, Morrisroe K, Blackwell W, Dasgupta A. Rapid automated determination of lipid hydroperoxide concentrations and total antioxidant status of serum samples from patients infected with HIV: elevated lipid hydroperoxide concentrations and depleted total antioxidant capacity of serum samples. American Journal of Clinical Pathology 1998; 109(3): 268-73.
17. Masutani H, Naito M, Takahashi K, et al. Dysregulation of adult Tcell leukemia-derived factor (ADF)/thioredoxin in HIV infection: loss of ADF high-producer cells in lymphoid tissues of AIDS patients. AIDS Research and Human Retroviruses 1992; 8(9): 1707-15.
18. Price TO, Ercal N, Nakaoke R, Banks WA. HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells. Brain Research 2005; 1045(1-2): 57-63.
19. Foga IO, Nath A, Hasinoff BB, Geiger JD. Antioxidants and dipyridamole inhibit HIV-1 gp120-induced free radical-based oxidative damage to human monocytoid cells. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1997; 16(4): 223-9.
20. Otis JS, Ashikhmin YI, Brown LAS, Guidot DM. Effect of HIV-1-related protein expression on cardiac and skeletal muscles from transgenic rats. AIDS Research and Therapy 2008; 5: 8.
21. Yu Q-R, Zhang Z-P, Zhang H, et al. Inducible nitric oxide synthase is involved in the oxidation stress induced by HIV-1 gp120 in human retina pigment epithelial cells. Chinese Medical Journal 2008; 121(24): 2578-83.
22. Radrizzani M, Accornero P, Delia D, Kurrle R, Colombo MP. Apoptosis induced by HIV-gp120 in a Th1 clone involves the generation of reactive oxygen intermediates downstream CD95 triggering. FEBS Letters 1997; 411(1): 87-92.
23. Stromájer-Rácz T, Gazdag Z, Belágyi J, Vágvölgyi C, Zhao RY, Pesti M. Oxidative stress induced by HIV-1 F34IVpr in Schizosaccharomyces pombe is one of its multiple functions. Experimental and Molecular Pathology 2010; 88(1): 38-44.
24. Poli G, Fauci AS. The effect of cytokines and pharmacologic agents on chronic HIV infection. AIDS Research and Human Retroviruses 1992; 8(2): 191-7.
25. Palamara AT, Perno CF, Aquaro S, Buè MC, Dini L, Garaci E. Glutathione inhibits HIV replication by acting at late stages of the virus life cycle. AIDS Research and Human Retroviruses 1996; 12(16): 1537-41.
26. Israel N, Gougerot-Pocidalo MA. Oxidative stress in human immunodeficiency virus infection. Cellular and Molecular Life Sciences 1997; 53(11-12): 864-70.
27. Roc AC, Ances BM, Chawla S, et al. Detection of human immunodeficiency virus induced inflammation and oxidative stress in lenticular nuclei with magnetic resonance spectroscopy despite antiretroviral therapy. Archives of Neurology 2007; 64(9): 1249-57.
28. Reddy PVB, Agudelo M, Atluri VSR, Nair MP. Inhibition of nuclear factor erythroid 2-related factor 2 exacerbates HIV-1 gp120-induced oxidative and inflammatory response: role in HIV associated neurocognitive disorder. Neurochemical Research 2012; 37(8): 1697-706.
29. Fuchs J, Oelke N, Imhof M, et al. Multiparameter analysis of clastogenic factors, pro-oxidant cytokines, and inflammatory markers in HIV-1-infected patients with asymptomatic disease, opportunistic infections, and malignancies. Molecular Medicine 1998; 4(5): 333-43.
30. Toborek M, Lee YW, Pu H, et al. HIV-Tat protein induces oxidative and inflammatory pathways in brain endothelium. Journal of Neurochemistry 2003; 84(1): 169-79.
31. Driscoll KE. TNFalpha and MIP-2: role in particle-induced inflammation and regulation by oxidative stress. Toxicology Letters 2000; 112-113: 177-83.
32. Wanchu A, Rana SV, Pallikkuth S, Sachdeva RK. Short communication: oxidative stress in HIV-infected individuals: a cross-sectional study. AIDS Research and Human Retroviruses 2009; 25(12): 1307-11.
33. Ibeh BO, Emeka-Nwabunnia IK. Increased oxidative stress condition found in different stages of HIV disease in patients undergoing antiretroviral therapy in Umuahia (Nigeria). Immunopharmacology and Immunotoxicology 2012; 34(6): 1060-6.
34. Suresh DR, Annam V, Pratibha K, Prasad BV. Total antioxidant capacity--a novel early bio-chemical marker of oxidative stress in HIV infected individuals. Journal of Biomedical Science 2009; 16: 61.
35. Haughey NJ, Cutler RG, Tamara A, et al. Perturbation of sphingolipid metabolism and ceramide production in HIVdementia. Annals of Neurology 2004; 55(2): 257-67.
36. Bandaru VV, McArthur JC, Sacktor N, et al. Associative and predictive biomarkers of dementia in HIV-1-infected patients. Neurology 2007; 68(18): 1481-7.
37. Turchan J, Pocernich CB, Gairola C, et al. Oxidative stress in HIV demented patients and protection ex vivo with novel antioxidants. Neurology 2003; 60(2): 307-14.
38. Viviani B, Corsini E, Binaglia M, Galli CL, Marinovich M. Reactive oxygen species generated by glia are responsible for neuron death induced by human immunodeficiency virusglycoprotein 120 in vitro. Neuroscience 2001; 107(1): 51-8.
39. Ferrucci A, Nonnemacher MR, Cohen EA, Wigdahl B. Extracellular human immunodeficiency virus type 1 viral protein R causes reductions in astrocytic ATP and glutathione levels compromising the antioxidant reservoir. Virus Research 2012; 167(2): 358-69.
40. Shi B, Raina J, Lorenzo A, Busciglio J, Gabuzda D. Neuronal apoptosis induced by HIV-1 Tat protein and TNF-alpha: potentiation of neurotoxicity mediated by oxidative stress and implications for HIV-1 dementia. Journal of Neurovirology 1998; 4(3): 281-90.
41. Tian C, Sun L, Jia B, et al. Mitochondrial glutaminase release contributes to glutamate-mediated neurotoxicity during human immunodeficiency virus-1 infection. Journal of Neuroimmune Pharmacology 2012; 7(3): 619-28.
42. Velazquez I, Plaud M, Wojna V, Skolasky R, Laspiur JP, Melendez LM. Antioxidant enzyme dysfunction in monocytes and CSF of Hispanic women with HIV-associated cognitive impairment. Journal of Neuroimmunology 2009; 206(1-2): 106-11.
43. Zhang Y, Wang M, Li H, et al. Accumulation of nuclear and mitochondrial DNA damage in the frontal cortex cells of patients with HIV-associated neurocognitive disorders. Brain Research 2012; 1458: 1-11.
44. Mattson MP, Haughey NJ, Nath A. Cell death in HIV dementia. Cell Death and Differentiation 2005; 12 Suppl 1: 893-904.
45. Sacktor N, Haughey N, Cutler R, et al. Novel markers of oxidative stress in actively progressive HIV dementia. Journal of Neuroimmunology 2004; 157(1-2): 176-84.
46. Gelman BB. HIV-1 Neuropathology. The Neurology of AIDS. 2012; In: Gendelman HEG I, Everall IP, Fox HS, Gelbard HA, Lipton SA, Swindells S, editors.
47. Wiestler OD, Leib SL, Brustle O, Spiegel H, Kleihues P. Neuropathology and pathogenesis of HIV encephalopathies. Acta Histochem Suppl. 1992; 42: 107-14.
48. Bell JE. An update on the neuropathology of HIV in the HAART era. Histopathology. 2004; 45(6): 549-59.
49. Morgello S, Mahboob R, Yakoushina T, Khan S, Hague K. Autopsy findings in a human immunodeficiency virus-infected population over 2 decades: influences of gender, ethnicity, risk factors, and time. Archives of Pathology and Laboratory Medicine 2002; 126(2): 182-90.
50. Langford TD, Letendre SL, Larrea GJ, Masliah E. Changing patterns in the neuropathogenesis of HIV during the HAART era. Brain Pathology 2003; 13(2): 195-210.
51. Anthony IC, Ramage SN, Carnie FW, Simmonds P, Bell JE. Influence of HAART on HIV-related CNS disease and neuroinflammation. Journal of Neuropathology and Experimental Neurology 2005; 64(6): 529-36.
52. Anthony IC, Ramage SN, Carnie FW, Simmonds P, Bell JE. Accelerated Tau deposition in the brains of individuals infected with human immunodeficiency virus-1 before and after the advent of highly active anti-retroviral therapy. Acta Neuropathologica 2006; 111(6): 529-38.
53. Anthony IC, Bell P. The neuropathology of HIV/AIDS. International Review of Psychiatry 2008; 20(1): 15-24.
54. Morgello S, Estanislao L, Simpson D, et al. HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: the Manhattan HIV Brain Bank. Archives of Neurology 2004; 61(4): 546-51.
55. Backe E, Schwarting R, Gerdes J, Ernst M, Stein H. Ber-MAC3: new monoclonal antibody that defines human monocyte/macrophage differentiation antigen. Journal of Clinical Pathology 1991; 44(11): 936-45.
56. Buechler C, Ritter M, Orsó E. Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by proand antiinflammatory stimuli. Journal of Leukocyte Biology 2000; 67(1): 97-103.
57. Hintz KA, Rassias AJ, Wardwell K, et al. Endotoxin induces rapid metalloproteinase-mediated shedding followed by up-regulation of the monocyte hemoglobin scavenger receptor CD163. Journal of Leukocyte Biology 2002; 72(4): 711-7.
58. Weaver LK, Hintz-Goldstein KA. Pivotal advance: activation of cell surface Toll-like receptors causes shedding of the hemoglobin scavenger receptor CD163. Journal of Leukocyte Biology 2006; 80(1): 26-35.
59. Weaver LK, Pioli PA, Wardwell K, Vogel SN, Guyre PM. Upregulation of human monocyte CD163 upon activation of cellsurface Toll-like receptors. Journal of Leukocyte Biology 2007; 81(3): 663-71.
60. Timmermann M, Högger P. Oxidative stress and 8-isoprostaglandin F(2alpha) induce ectodomain shedding of CD163 and release of tumor necrosis factor-alpha from human monocytes. Free Radical Biology and Medicine 2005; 39(1): 98-107.
61. Neaton JD, Neuhaus J, Emery S. Soluble biomarkers and morbidity and mortality among people infected with HIV: summary of published reports from 1997-2010. Current Opinion in HIV and AIDS 2010; 5(6): 480-90.
62. Nixon DE, Landay AL. Biomarkers of immune dysfunction in HIV. Current Opinion in HIV and AIDS 2010; 5(6): 498-503.
63. Lyons JL, Uno H, Ancuta P, et al. Plasma sCD14 is a biomarker associated with impaired neurocognitive test performance in attention and learning domains in HIV infection. Journal of Acquired Immune Deficiency Syndromes 2011; 57(5): 371-9.
64. Burdo TH, Lentz MR, Autissier P, et al. Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy. Journal of Infectious Diseases 2011; 204(1): 154-63.
65. Burdo TH, Lo J, Abbara S, et al. Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients. Journal of Infectious Diseases 2011; 204(8): 1227-36.
66. Burdo TH, Weiffenbach A, Woods SP, Letendre S. Elevated sCD163 in plasma but not cerebrospinal fluid is a marker of neurocognitive impairment in HIV infection. AIDS. 2013;27(9):1387-95.
67. Kamat A, Lyons JL, Misra V, et al. Monocyte activation markers in cerebrospinal fluid associated with impaired neurocognitive testing in advanced HIV infection. Journal of Acquired Immune Deficiency Syndromes 2012; 60(3): 234-43.
68. Nolting T, Lindecke A, Hartung H-P, et al. Cytokine levels in CSF and neuropsychological performance in HIV patients. Journal of Neurovirology 2012; 18(3): 157-61.
69. Glass JD, Fedor H, Wesselingh SL, McArthur JC. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Annals of Neurology 1995; 38(5): 755-62.
70. Masliah E, Heaton RK, Marcotte TD, et al. Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Annals of Neurology 1997; 42(6): 963-72.
71. Wesselingh SL, Takahashi K, Glass JD, McArthur JC, Griffin JW, Griffin DE. Cellular localization of tumor necrosis factor mRNA in neurological tissue from HIV-infected patients by combined reverse transcriptase/polymerase chain reaction in situ hybridization and immunohistochemistry. Journal of Neuroimmunology 1997; 74(1-2): 1-8.
72. Kaul M, Zheng J, Okamoto S, Gendelman HE, Lipton SA. HIV-1 infection and AIDS: consequences for the central nervous system. Cell Death and Differentiation. 2005;12 (Suppl 1):878-92.
73. Williams KC, Corey S, Westmoreland SV, et al. Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS. Journal of Experimental Medicine 2001; 193(8): 905-15.
74. González-Scarano F, Martín-García J. The neuropathogenesis of AIDS. Nature Reviews Immunology 2005; 5(1): 69-81.
75. Kaul M, Garden GA, Lipton SA. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 2001; 410(6831): 988-94.
76. Mörner A, Thomas JA, Björling E, Munson PJ, Lucas SB, McKnight A. Productive HIV-2 infection in the brain is restricted to macrophages/microglia. AIDS 2003; 17(10): 1451-5.
77. Schnell G, Spudich S, Harrington P, Price RW, Swanstrom R. Compartmentalized human immunodeficiency virus type 1 originates from long-lived cells in some subjects with HIV-1-associated dementia. PLoS Pathogens. 2009;5(4):e1000395.
78. Schnell G, Joseph S, Spudich S, Price RW, Swanstrom R. HIV-1 replication in the central nervous system occurs in two distinct cell types. PLoS Pathogens 2011; 7(10): e1002286.
79. Petito CK. Human immunodeficiency virus type 1 compartmentalization in the central nervous system. Journal of Neurovirology 2004; 10 Suppl 1: 21-4.
80. Nottet HS, Persidsky Y, Sasseville VG, et al. Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain. Journal of Immunology 1996; 156(3): 1284-95.
81. Bagasra O, Lavi E, Bobroski L, et al. Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry. AIDS 1996; 10(6): 573-85.
82. Mukhtar M, Pomerantz RJ. Development of an in vitro blood-brain barrier model to study molecular neuropathogenesis and neurovirologic disorders induced by human immunodeficiency virus type 1 infection. Journal of Human Virology 2000; 3(6): 324-34.
83. Gujuluva C, Burns AR, Pushkarsky T, et al. HIV-1 penetrates coronary artery endothelial cells by transcytosis. Molecular Medicine 2001; 7(3): 169-76.
84. Liu NQ, Lossinsky AS, Popik W, et al. Human immunodeficiency virus type 1 enters brain microvascular endothelia by macropinocytosis dependent on lipid rafts and the mitogenactivated protein kinase signaling pathway. Journal of Virology. 2002;76(13):6689-700.
85. Argyris EG, Acheampong E, Nunnari G, Mukhtar M, Williams KJ, Pomerantz RJ. Human immunodeficiency virus type 1 enters primary human brain microvascular endothelial cells by a mechanism involving cell surface proteoglycans independent of lipid rafts. Journal of Virology 2003; 77(22): 12140-51.
86. Willey SJ, Reeves JD, Hudson R, et al. Identification of a subset of human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus strains able to exploit an alternative coreceptor on untransformed human brain and lymphoid cells. Journal of Virology 2003; 77(11): 6138-52.
87. Fischer-Smith T, Rappaport J. Evolving paradigms in the pathogenesis of HIV-1-associated dementia. Expert Reviews in Molecular Medicine 2005; 7(27): 1-26.
88. Masliah E, Ge N, Morey M, DeTeresa R, Terry RD, Wiley CA. Cortical dendritic pathology in human immunodeficiency virus encephalitis. Laboratory Investigation 1992; 66(3): 285-91.
89. Wiley CA, Masliah E, Morey M, et al. Neocortical damage during HIV infection. Annals of Neurology 1991; 29(6): 651-7.
90. Gelbard HA, James HJ, Sharer LR, et al. Apoptotic neurons in brains from paediatric patients with HIV-1 encephalitis and progressive encephalopathy. Neuropathology and Applied Neurobiology 1995; 21(3): 208-17.
91. Petito CK, Roberts B. Evidence of apoptotic cell death in HIV encephalitis. American Journal of Pathology 1995; 146(5): 1121-30.
92. Adamson DC, Dawson TM, Zink MC, Clements JE, Dawson VL. Neurovirulent simian immunodeficiency virus infection induces neuronal, endothelial, and glial apoptosis. Molecular Medicine 1996; 2(4): 417-28.
93. Gelman BB, Soukup VM, Schuenke KW, et al. Acquired neuronal channelopathies in HIV-associated dementia. Journal of Neuroimmunology 2004; 157(1-2): 111-9.
94. Hu D, Liu J, Xiong H. Enhancement of neuronal outward delayed rectifier K+ current by human monocyte-derived macrophages. Glia 2009; 57(14): 1492-500.
95. Hu D, Liu J, Keblesh J, Xiong H. Involvement of the 4-aminopyridine-sensitive transient A-type K+ current in macrophage-induced neuronal injury. European Journal of Neuroscience 2010; 31(2): 214-22.
96. Xiong H, Zeng YC, Zheng J, Thylin M, Gendelman HE. Soluble HIV-1 infected macrophage secretory products mediate blockade of long-term potentiation: a mechanism for cognitive dysfunction in HIV-1-associated dementia. Journal of Neurovirology 1999; 5(5): 519-28.
97. Dong J, Xiong H. Human immunodeficiency virus type 1 gp120 inhibits long-term potentiation via chemokine receptor CXCR4 in rat hippocampal slices. Journal of Neuroscience Research. 2006; 83(3): 489-96.
98. Behnisch T, Francesconi W, Sanna PP. HIV secreted protein Tat prevents long-term potentiation in the hippocampal CA1 region. Brain Research 2004; 1012(1-2): 187-9.
99. Anderson ER, Boyle J, Zink WE, Persidsky Y, Gendelman HE, Xiong H. Hippocampal synaptic dysfunction in a murine model of human immunodeficiency virus type 1 encephalitis. Neuroscience. 2003; 118(2): 359-69.
100. Gelman BB, Nguyen TP. Synaptic proteins linked to HIV-1 infection and immunoproteasome induction: proteomic analysis of human synaptosomes. Journal of Neuroimmune Pharmacology. 2010; 5(1): 92-102.
101. Ellis R, Langford D, Masliah E. HIV and antiretroviral therapy in the brain: neuronal injury and repair. Nature Reviews Neuroscience 2007; 8(1): 33-44.
102. Deshpande M, Zheng J, Borgmann K, et al. Role of activated astrocytes in neuronal damage: potential links to HIV-1-associated dementia. Neurotoxicity Research 2005; 7(3): 183-92.
103. Li W, Galey D, Mattson MP, Nath A. Molecular and cellular mechanisms of neuronal cell death in HIV dementia. Neurotoxicity Research 2005; 8(1-2): 119-34.
104. Cisneros IE, Ghorpade A. HIV-1, methamphetamine and astrocyte glutamate regulation: combined excitotoxic implications for neuro-AIDS. Current HIV Research 2012; 10(5): 392-406.
105. Fan Y, Zou W, Green LA, Kim BO, He JJ. Activation of Egr-1 expression in astrocytes by HIV-1 Tat: new insights into astrocytemediated Tat neurotoxicity. Journal of Neuroimmune Pharmacology. 2011; 6(1): 121-9.
106. O'Donnell LA, Agrawal A, Jordan-Sciutto KL, Dichter MA, Lynch DR, Kolson DL. Human immunodeficiency virus (HIV)-induced neurotoxicity: roles for the NMDA receptor subtypes. Journal of Neuroscience. 2006; 26(3): 981-90.
107. Anderson ER, Gendelman HE, Xiong H. Memantine protects hippocampal neuronal function in murine human immunodeficiency virus type 1 encephalitis. Journal of Neuroscience 2004; 24(32): 7194-8.
108. Meisner F, Scheller C, Kneitz S, et al. Memantine upregulates BDNF and prevents dopamine deficits in SIV-infected macaques: a novel pharmacological action of memantine. Neuropsychopharmacology 2008; 33(9): 2228-36.
109. Jiang ZG, Piggee C, Heyes MP, et al. Glutamate is a mediator of neurotoxicity in secretions of activated HIV-1-infected macrophages. Journal of Neuroimmunology 2001; 117(1-2): 97-107.
110. Heyes MP, Brew BJ, Martin A, et al. Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Annals of Neurology 1991; 29(2): 202-9.
111. Heyes MP, Brew BJ, Saito K, et al. Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and beta 2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients. Journal of Neuroimmunology 1992; 40(1): 71-80.
112. Giulian D, Yu J, Li X, et al. Study of receptor-mediated neurotoxins released by HIV-1-infected mononuclear phagocytes found in human brain. Journal of Neuroscience 1996; 16(10): 3139-53.
113. Gelbard HA, Nottet HS, Swindells S, et al. Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin. Journal of Virology 1994; 68(7): 4628-35.
114. Achim CL, Heyes MP, Wiley CA. Quantitation of human immunodeficiency virus, immune activation factors, and quinolinic acid in AIDS brains. Journal of Clinical Investigation 1993; 91(6): 2769-75.
115. Pulliam L, West D, Haigwood N, Swanson RA. HIV-1 envelope gp120 alters astrocytes in human brain cultures. AIDS Research and Human Retroviruses 1993; 9(5): 439-44.
116. Lipton SA. Requirement for macrophages in neuronal injury induced by HIV envelope protein gp120. Neuroreport. 1992; 3(10): 913-5.
117. Nath A. Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia. Journal of Infectious Diseases 2002; 186 Suppl 2: S193-8.
118. Ferrarese C, Aliprandi A, Tremolizzo L, et al. Increased glutamate in CSF and plasma of patients with HIV dementia. Neurology 2001; 57(4): 671-5.
119. Espey MG, Ellis RJ, Heaton RK, Basile AS. Relevance of glutamate levels in the CSF of patients with HIV-1-associated dementia complex. Neurology 1999; 53(5): 1144-5.
120. Espey MG, Basile AS, Heaton RK, Ellis RJ. Increased glutamate in CSF and plasma of patients with HIV dementia. Neurology. 2002;58(9):1439; author reply-40.
121. Martin A, Heyes MP, Salazar AM, et al. Progressive slowing of reaction time and increasing cerebrospinal fluid concentrations of quinolinic acid in HIV-infected individuals. Journal of Neuropsychiatry and Clinical Neurosciences 1992; 4(3): 270-9.
122. Shibahara S, Müller RM, Taguchi H. Transcriptional control of rat heme oxygenase by heat shock. Journal of Biological Chemistry 1987; 262(27): 12889-92.
123. Taketani S, Kohno H, Yoshinaga T, Tokunaga R. Induction of heme oxygenase in rat hepatoma cells by exposure to heavy metals and hyperthermia. Biochemistry International 1988; 17(4): 665-72.
124. Ewing JF, Haber SN, Maines MD. Normal and heat-induced patterns of expression of heme oxygenase-1 (HSP32) in rat brain: hyperthermia causes rapid induction of mRNA and protein. Journal of Neurochemistry 1992; 58(3): 1140-9.
125. Ewing JF, Maines MD. Rapid induction of heme oxygenase 1 mRNA and protein by hyperthermia in rat brain: heme oxygenase 2 is not a heat shock protein. Proceedings of the National Academy of Sciences of the United States of America 1991; 88(12): 5364-8.
126. Dwyer BE, Nishimura RN, De Vellis J, Yoshida T. Heme oxygenase is a heat shock protein and PEST protein in rat astroglial cells. Glia 1992; 5(4): 300-5.
127. Maines MD, Ewing JF. Stress response of the rat testis: in situ hydridization and immunohistochemical analysis of heme oxygenase-1 (HSP32) induction by hyperthermia. Biology of Reproduction 1996; 54(5): 1070-9.
128. Keyse SM, Tyrrell RM. Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite. Proceedings of the National Academy of Sciences 1989; 86(1): 99-103.
129. Paller MS, Nath KA, Rosenberg ME. Heme oxygenase is not expressed as a stress protein after renal ischemia. Journal of Laboratory and Clinical Medicine 1993; 122(3): 341-5.
130. Eyssen-Hernandez R, Ladoux A, Frelin C. Differential regulation of cardiac heme oxygenase-1 and vascular endothelial growth factor mRNA expressions by hemin, heavy metals, heat shock and anoxia. FEBS Letters 1996; 382(3): 229-33.
131. Nimura T, Weinstein PR, Massa SM, Panter S. Heme oxygenase-1 (HO-1) protein induction in rat brain following focal ischemia. Molecular Brain 1996; 37(1-2): 201-8.
132. Visner GA, Fogg S, Nick HS. Hyperoxia-responsive proteins in rat pulmonary microvascular endothelial cells. American Journal of Physiology 1996; 270(4): L517-L25.
133. Sunderman FW. Metal induction of heme oxygenase. Annals of the New York Academy of Sciences 1987; 514: 65-80.
134. Opanashuk LA, Finkelstein JN. Relationship of lead-induced proteins to stress response proteins in astroglial cells. Journal of Neuroscience Research 1995; 42(5): 623-32.
135. Stocker R. Induction of haem oxygenase as a defence against oxidative stress. Free Radical Research Communications 1990; 9(2): 101-12.
136. Clerget M, Polla BS. Erythrophagocytosis induces heat shock protein synthesis by human monocytes-macrophages. Proceedings of the National Academy of Sciences of the United States of America 1990; 87(3): 1081-5.
137. Saunders EL, Maines MD, Meredith MJ, Freeman ML. Enhancement of heme oxygenase-1 synthesis by glutathione depletion in Chinese hamster ovary cells. Archives of Biochemistry and Biophysics 1991; 288(2): 368-73.
138. Katoh T, Ohmori H, Murakami T, Karasaki Y, Higashi K, Muramatsu M. Induction of glutathione-S-transferase and heatshock proteins in rat liver after ethylene oxide exposure. Biochemical Pharmacology 1991; 42(6): 1247-54.
139. Sato H, Ishii T, Sugita Y, Tateishi N, Bannai S. Induction of a 23 kDa stress protein by oxidative and sulfhydryl-reactive agents in mouse peritoneal macrophages. Biochimica et Biophysica Acta 1993; 1148(1): 127-32.
140. Yamaguchi M, Sato H, Bannai S. Induction of stress proteins in mouse peritoneal macrophages by oxidized low-density lipoprotein. Biochemical and Biophysical Research Communications 1993; 193(3): 1198-201.
141. Hoshida S, Nishida M, Yamashita N, et al. Heme oxygenase-1 expression and its relation to oxidative stress during primary culture of cardiomyocytes. Journal of Molecular and Cellular Cardiology. 1996; 28(9): 1845-55.
142. McDonagh AF. Is bilirubin good for you? Clinics in Perinatology 1990; 17(2): 359-69.
143. Ryter SW, Choi AMK. Heme Oxygenase-1/Carbon Monoxide. American Journal of Respiratory Cell and Molecular Biology 2009; 41(3): 251-60.
144. Smith MA, Kutty RK, Richey PL, et al. Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. American Journal of Pathology 1994; 145(1): 42.
145. Schipper HM, Cissé S, Stopa EG. Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain. Annals of Neurology 1995; 37(6): 758-68.
146. Takeda A, Perry G, Abraham N, et al. Overexpression of Heme Oxygenase in Neuronal Cells, the Possible Interaction with Tau. Journal of Biological Chemistry 2000; 275(8): 5395-9.
147. Schipper HM, Liberman A, Stopa MD EG. Neural heme oxygenase-1 expression in idiopathic Parkinson's disease. Experimental Neurology 1998; 150(1): 60-8.
148. Castellani R, Smith MA, Richey PL, Perry G. Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease. Brain Research 1996; 737(1-2): 195-200.
149. Mateo I, Infante J, Sanchez-Juan P, et al. Serum heme oxygenase-1 levels are increased in Parkinson's disease but not in Alzheimer's disease. Acta Neurologica Scandinavica 2010; 121(2): 136-8.
150. Castellani R, Smith MA, Richey PL, Kalaria R, Gambetti P, Perry G. Evidence for oxidative stress in Pick disease and corticobasal degeneration. Brain Research 1995; 696(1-2): 268-71.
151. Browne SE, Ferrante RJ, Beal MF. Oxidative stress in Huntington's disease. Brain Pathology. 1999; 9(1): 147-63.
152. Mehindate K, Sahlas DJ, Frankel D, et al. Proinflammatory cytokines promote glial heme oxygenase-1 expression and mitochondrial iron deposition: implications for multiple sclerosis. Journal of Neurochemistry 2001; 77(5): 1386-95.
153. Fagone P, Patti F, Mangano K, et al. Heme oxygenase-1 expression in peripheral blood mononuclear cells correlates with disease activity in multiple sclerosis. Journal of Neuroimmunology 2013; 261(1-2): 82-6.
154. Schipper HM. Heme oxygenase-1: role in brain aging and neurodegeneration. Experimental Gerontology 2000; 35(6-7): 821-30.
155. Schipper HM. Heme oxygenase expression in human central nervous system disorders. Free Radical Biology and Medicine 2004; 37(12): 1995-2011.
156. Schipper HM, Gupta A, Szarek WA. Suppression of glial HO-1 activity as a potential neurotherapeutic intervention in AD. Current Alzheimer Research 2009; 6(5): 424-30.
157. Jazwa A, Cuadrado A. Targeting heme oxygenase-1 for neuroprotection and neuroinflammation in neurodegenerative diseases. Current Drug Targets 2010; 11(12): 1517-31.
158. Cross SA, Cook DR, Chi AWS, et al. Dimethyl Fumarate, an Immune Modulator and Inducer of the Antioxidant Response, Suppresses HIV Replication and Macrophage-Mediated Neurotoxicity: A Novel Candidate for HIV Neuroprotection. Journal of Immunology 2011; 187(10): 5015-25.
159. Bornman L, Baladi S, Richard MJ, Tyrrell RM, Polla BS. Differential regulation and expression of stress proteins and ferritin in human monocytes. Journal of Cellular Physiology 1999; 178(1): 1-8.
160. Kristiansen M, Graversen JH, Jacobsen C, et al. Identification of the haemoglobin scavenger receptor. Nature 2001; 409(6817): 198-201.
161. Schaer DJ, Schaer CA, Buehler PW, et al. CD163 is the macrophage scavenger receptor for native and chemically modified hemoglobins in the absence of haptoglobin. Blood 2006; 107(1): 373-80.
162. Schaer CA, Vallelian F, Imhof A, Schoedon G, Schaer DJ. CD163-expressing monocytes constitute an endotoxin-sensitive Hb clearance compartment within the vascular system. Journal of Leukocyte Biology 2007; 82(1): 106-10.
163. Philippidis P, Mason JC, Evans BJ, et al. Hemoglobin scavenger receptor CD163 mediates interleukin-10 release and heme oxygenase-1 synthesis: antiinflammatory monocyte-macrophage responses in vitro, in resolving skin blisters in vivo, and after cardiopulmonary bypass surgery. Circulation Research 2004; 94(1): 119-26.
164. Delaby C, Pilard N, Hetet G, et al. A physiological model to study iron recycling in macrophages. Experimental Cell Research 2005; 310(1): 43-53.
165. Schaer CA, Schoedon G, Imhof A, Kurrer MO, Schaer DJ. Constitutive endocytosis of CD163 mediates hemoglobin-heme uptake and determines the noninflammatory and protective transcriptional response of macrophages to hemoglobin. Circulation Research 2006; 99(9): 943-50.
166. Kovtunovych G, Eckhaus MA, Ghosh MC, Ollivierre-Wilson H, Rouault TA. Dysfunction of the heme recycling system in heme oxygenase 1-deficient mice: effects on macrophage viability and tissue iron distribution. Blood 2010; 116(26): 6054-62.
167. Turcanu V, Dhouib M, Poindron P. Nitric oxide synthase inhibition by haem oxygenase decreases macrophage nitric-oxide-dependent cytotoxicity: a negative feedback mechanism for the regulation of nitric oxide production. Research in Immunology 1998; 149(7-8): 741-4.
168. Wagener FADTG, van Beurden HE, von den Hoff JW, Adema GJ, Figdor CG. The heme-heme oxygenase system: a molecular switch in wound healing. Blood 2003; 102(2): 521-8.
169. Lang D, Reuter S, Buzescu T, August C, Heidenreich S. Hemeinduced heme oxygenase-1 (HO-1) in human monocytes inhibits apoptosis despite caspase-3 up-regulation. International Immunology 2005; 17(2): 155-65.
170. Hvidberg V, Maniecki MB, Jacobsen C, Højrup P, Møller HJ, Moestrup SK. Identification of the receptor scavenging hemopexinheme complexes. Blood 2005; 106(7): 2572-9.
171. Gleissner CA, Shaked I, Erbel C, Böckler D, Katus HA, Ley K. CXCL4 downregulates the atheroprotective hemoglobin receptor CD163 in human macrophages. Circulation Research 2010; 106(1): 203-11.
172. Vallelian F, Pimenova T, Pereira CP, et al. The reaction of hydrogen peroxide with hemoglobin induces extensive alphaglobin crosslinking and impairs the interaction of hemoglobin with endogenous scavenger pathways. Free Radical Biology and Medicine 2008; 45(8): 1150-8.
173. Srisook K, Cha YN. Super-induction of HO-1 in macrophages stimulated with lipopolysaccharide by prior depletion of glutathione decreases iNOS expression and NO production. Nitric Oxide 2005; 12(2): 70-9.
174. Pham N-K, Mouriz J, Kima PE. Leishmania pifanoi amastigotes avoid macrophage production of superoxide by inducing heme degradation. Infection and Immunity 2005; 73(12): 8322-33.
175. Orozco LD, Kapturczak MH, Barajas B, et al. Heme oxygenase-1 expression in macrophages plays a beneficial role in atherosclerosis. Circulation Research 2007; 100(12): 1703-11.
176. Taketani S, Sato H, Yoshinaga T, Tokunaga R, Ishii T, Bannai S. Induction in mouse peritoneal macrophages of 34 kDa stress protein and heme oxygenase by sulfhydryl-reactive agents. Journal of Biochemistry 1990; 108(1): 28-32.
177. Paine A, Eiz-Vesper B, Blasczyk R. Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential. Biochemical Pharmacology 2010; 80(12): 1895-903.
178. Srisook K, Kim C, Cha YN. Cytotoxic and cytoprotective actions of O2-and NO (ONOO-) are determined both by cellular GSH level and HO activity in macrophages. Methods in Enzymology 2005; 396: 414-24.
179. Ryter S, Choi A. Heme oxygenase-1: molecular mechanisms of gene expression in oxygen-related stress. Antioxidants and Redox Signaling 2002; 4(4): 625-32.
180. Camhi SL, Alam J, Otterbein L, Sylvester SL, Choi AM. Induction of heme oxygenase-1 gene expression by lipopolysaccharide is mediated by AP-1 activation. American Journal of Respiratory Cell and Molecular Biology 1995; 13(4): 387-98.
181. Kurata S, Matsumoto M, Tsuji Y, Nakajima H. Lipopolysaccharide activates transcription of the heme oxygenase gene in mouse M1 cells through oxidative activation of nuclear factor kappa B. European Journal of Biochemistry 1996; 239(3): 566-71.
182. Song Y, Shi Y, Ao L-H, Harken AH, Meng X-Z. TLR4 mediates LPS-induced HO-1 expression in mouse liver: role of TNF-alpha and IL-1beta. World Journal of Gastroenterology 2003; 9(8): 1799-803.
183. Devadas K, Hewlett IK, Dhawan S. Lipopolysaccharide suppresses HIV-1 replication in human monocytes by protein kinase Cdependent heme oxygenase-1 induction. Journal of Leukocyte Biology 2010; 87(5): 915-24.
184. Connor AJ, Chen LC, Joseph LB, Laskin JD, Laskin DL. Distinct responses of lung and liver macrophages to acute endotoxemia. Experimental and Molecular Pathology 2013; 94(1): 216-27.
185. Yachie A, Toma T, Mizuno K, et al. Heme oxygenase-1 production by peripheral blood monocytes during acute inflammatory illnesses of children. Experimental Biology and Medicine 2003; 228(5): 550-6.
186. Regev D, Surolia R, Karki S, et al. Heme oxygenase-1 promotes granuloma development and protects against dissemination of mycobacteria. Laboratory Investigation 2012; 92(11): 1541-52.
187. Zacharia VM, Shiloh MU. Effect of carbon monoxide on Mycobacterium tuberculosis pathogenesis. Medical Gas Research 2012; 2(1): 30.
188. Fujii S, Akaike T, Maeda H. Role of nitric oxide in pathogenesis of herpes simplex virus encephalitis in rats. Virology 1999; 256(2): 203-12.
189. Schachtele SJ, Hu S, Lokensgard JR. Modulation of experimental herpes encephalitis-associated neurotoxicity through sulforaphane treatment. PLoS One 2012; 7(4): e36216.
190. Herden C, Schluesener HJ, Richt JA. Expression of allograft inflammatory factor-1 and haeme oxygenase-1 in brains of rats infected with the neurotropic Borna disease virus. Neuropathology and Applied Neurobiology 2005; 31(5): 512-21.
191. Luz NF, Andrade BB, Feijo DF, et al. Heme Oxygenase-1 Promotes the Persistence of Leishmania chagasi Infection. Journal of Immunology 2012; 188(9): 4460-7.
192. El Fadili K, Imbeault M, Messier N, et al. Modulation of gene expression in human macrophages treated with the anti-leishmania pentavalent antimonial drug sodium stibogluconate. Antimicrobial Agents and Chemotherapy 2008; 52(2): 526-33.
193. Epiphanio S, Mikolajczak SA, Gonçalves LA, et al. Heme oxygenase-1 is an anti-inflammatory host factor that promotes murine plasmodium liver infection. Cell Host and Microbe 2008; 3(5): 331-8.
194. Mendonça VRR, Luz NF, Santos NJG, et al. Association between the haptoglobin and heme oxygenase 1 genetic profiles and soluble CD163 in susceptibility to and severity of human malaria. Infection and Immunity 2012; 80(4): 1445-54.
195. Cunnington AJ, Njie M, Correa S, Takem EN, Riley EM, Walther M. Prolonged Neutrophil Dysfunction after Plasmodium falciparum Malaria Is Related to Hemolysis and Heme Oxygenase-1 Induction. Journal of Immunology 2012; 189(11): 5336-46.
196. Walther M, De Caul A, Aka P, et al. HMOX1 Gene Promoter Alleles and High HO-1 Levels Are Associated with Severe Malaria in Gambian Children. PLoS Pathogens 2012; 8(3): e1002579.
197. Dey S, Bindu S, Goyal M, Pal C, Alam A, Iqbal MS, et al. Impact of intravascular hemolysis in malaria on liver dysfunction: involvement of hepatic free heme overload, NF-κB activation, and neutrophil infiltration. Journal of Biological Chemistry 2012; 287(32): 26630-46.
198. Schluesener H, Kremsner P, Meyermann R. Heme oxygenase-1 in lesions of human cerebral malaria. Acta Neuropathologica 2001; 101(1): 65-8.
199. Pamplona A, Ferreira A, Balla J, et al. Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria. Nature Medicine 2007; 13(6): 703-10.
200. Seixas E, Gozzelino R, Chora A, et al. Heme oxygenase-1 affords protection against noncerebral forms of severe malaria. Proceedings of the National Academy of Sciences of the United States of America 2009; 106(37): 15837-42.
201. Mautes AE, Kim DH, Sharp FR, et al. Induction of heme oxygenase-1 (HO-1) in the contused spinal cord of the rat. Brain Research 1998; 795(1-2): 17-24.
202. Magnusson S, Ekström TJ, Elmér E, Kanje M, Ny L, Alm P. Heme oxygenase-1, heme oxygenase-2 and biliverdin reductase in peripheral ganglia from rat, expression and plasticity. Neuroscience 2000; 95(3): 821-9.
203. Mautes AE, Bergeron M, Sharp FR, et al. Sustained induction of heme oxygenase-1 in the traumatized spinal cord. Experimental Neurology 2000; 166(2): 254-65.
204. Koistinaho J, Miettinen S, Keinänen R, Vartiainen N, Roivainen R, Laitinen JT. Long-term induction of haem oxygenase-1 (HSP-32) in astrocytes and microglia following transient focal brain ischaemia in the rat. European Journal of Neuroscience 1996; 8(11): 2265-72.
205. Dwyer BE, Nishimura RN, Lu SY, Alcaraz A. Transient induction of heme oxygenase after cortical stab wound injury. Brain Research Molecular Brain Research 1996; 38(2): 251-9.
206. Orihara Y, Tsuda R, Ikematsu K, Nakasono I, Ogata M. Immunohistochemical study on the induction of heme oxygenase-1 by traumatic brain injury. Legal Medicine 2003; 5 (Suppl 1):S278-9.
207. Sutherland BA, Rahman RMA, Clarkson AN, Shaw OM, Nair SM, Appleton I. Cerebral heme oxygenase 1 and 2 spatial distribution is modulated following injury from hypoxia-ischemia and middle cerebral artery occlusion in rats. Neuroscience Research 2009; 65(4): 326-34.
208. Fukuda K, Richmon JD, Sato M, Sharp FR, Panter SS, Noble LJ. Induction of heme oxygenase-1 (HO-1) in glia after traumatic brain injury. Brain Research 1996; 736(1-2): 68-75.
209. Hirata K, He JW, Kuraoka A, et al. Heme oxygenase1 (HSP-32) is induced in myelin-phagocytosing Schwann cells of injured sciatic nerves in the rat. European Journal of Neuroscience 2000; 12(11): 4147-52.
210. Jelinski SE, Yager JY, Juurlink BH. Preferential injury of oligodendroblasts by a short hypoxic-ischemic insult. Brain Research 1999; 815(1): 150-3.
211. Fukuda K, Scott Panter S, Sharp FR, Noble LJ. Induction of heme oxygenase-1 (HO-1) after traumatic brain injury in the rat. Neuroscience Letters 1995; 199(2): 127-30.
212. Wang J, Doré S. Heme oxygenase-1 exacerbates early brain injury after intracerebral haemorrhage. Brain 2007; 130(Pt 6): 1643-52.
213. Zhang Z, Zhang Z-Y, Wu Y, Schluesener HJ. Lesional accumulation of CD163+ macrophages/microglia in rat traumatic brain injury. Brain Research 2012; 1461: 102-10.
214. Liu Y, Zhang Z, Luo B, Schluesener HJ, Zhang Z. Lesional accumulation of heme oxygenase-1+ microglia/macrophages in rat traumatic brain injury. Neuroreport 2013; 24(6): 281-6.
215. Richmon JD, Fukuda K, Maida N, et al. Induction of heme oxygenase-1 after hyperosmotic opening of the blood-brain barrier. Brain Research 1998; 780(1): 108-18.
216. Beschorner R, Adjodah D, Schwab JM, et al. Long-term expression of heme oxygenase-1 (HO-1, HSP-32) following focal cerebral infarctions and traumatic brain injury in humans. Acta Neuropathologica 2000; 100(4): 377-84.
217. Jofre-Monseny L, Loboda A, Wagner AE, et al. Effects of apoE genotype on macrophage inflammation and heme oxygenase-1 expression. Biochemical and Biophysical Research Communications 2007; 357(1): 319-24.
218. Nijboer WN, Schuurs TA, van der Hoeven JAB, et al. Effect of brain death on gene expression and tissue activation in human donor kidneys. Transplantation 2004; 78(7): 978-86.
219. Yan W, Wang H-D, Zhu L, et al. Traumatic brain injury induces the activation of the Nrf2-ARE pathway in the lung in rats. Brain Injury 2008; 22(10): 802-10.
220. Acarin L, Paris J, González B, Castellano B. Glial expression of small heat shock proteins following an excitotoxic lesion in the immature rat brain. Glia 2002; 38(1): 1-14.
221. Krause D, Suh H-S, Tarassishin L, et al. The tryptophan metabolite 3-hydroxyanthranilic acid plays anti-inflammatory and neuroprotective roles during inflammation: role of hemeoxygenase-1. American Journal of Pathology 2011; 179(3): 1360-72.
222. Tzima S, Victoratos P, Kranidioti K, Alexiou M, Kollias G. Myeloid heme oxygenase-1 regulates innate immunity and autoimmunity by modulating IFN-beta production. Journal of Experimental Medicine. 2009; 206(5): 1167-79.
223. Yamada K, Tanaka N, Nakanishi K, et al. Modulation of the secondary injury process after spinal cord injury in Bach1-deficient mice by heme oxygenase-1. Journal of Neurosurgery Spine 2008; 9(6): 611-20.
224. Wang J, Doré S. Heme oxygenase 2 deficiency increases brain swelling and inflammation after intracerebral hemorrhage. Neuroscience 2008; 155(4): 1133-41.
225. Grochot-Przeczek A, Dulak J, Jozkowicz A. Haem oxygenase-1: non-canonical roles in physiology and pathology. Clinical Science 2012; 122(3): 93-103.
226. Ishii T, Itoh K, Takahashi S, et al. Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. Journal of Biological Chemistry 2000; 275(21): 16023-9.
227. Vijayan V, Baumgart-Vogt E, Naidu S, Qian G, Immenschuh S. Bruton's tyrosine kinase is required for TLR-dependent heme oxygenase-1 gene activation via Nrf2 in macrophages. Journal of Immunology 2011; 187(2): 817-27.
228. Kim KH, Lyu JH, Koo ST, et al. MyD88 is a mediator for the activation of Nrf2. Biochemical and Biophysical Research Communications 2011; 404(1): 46-51.
229. Mandal P, Roychowdhury S, Park PH. Adiponectin and heme oxygenase-1 suppress TLR4/MyD88-independent signaling in rat Kupffer cells and in mice after chronic ethanol exposure. Journal of Immunology 2010; 185(8): 4928-37.
230. Yin H, Li X, Yuan B, et al. Heme oxygenase-1 ameliorates LPSinduced acute lung injury correlated with downregulation of interleukin-33. International Immunopharmacology 2011; 11(12): 2112-7.
231. Wang XM, Kim HP, Nakahira K, Ryter SW, Choi AMK. The heme oxygenase-1/carbon monoxide pathway suppresses TLR4 signaling by regulating the interaction of TLR4 with caveolin-1. Journal of Immunology 2009; 182(6): 3809-18.
232. Ke B, Shen X-D, Ji H, et al. HO-1-STAT3 axis in mouse liver ischemia/reperfusion injury: regulation of TLR4 innate responses through PI3K/PTEN signaling. Journal of Hepatology 2012; 56(2): 359-66.
233. Tsoyi K, Jang HJ, Kim JW, et al. Stimulation of alpha7 nicotinic acetylcholine receptor by nicotine attenuates inflammatory response in macrophages and improves survival in experimental model of sepsis through heme oxygenase-1 induction. Antioxidants and Redox Signaling 2011; 14(11): 2057-70.
234. Sun J, Kim SJ, Park MK, et al. Selective activation of adrenergic beta1 receptors induces heme oxygenase 1 production in RAW264.7 cells. FEBS Letters 2005; 579(25): 5494-500.
235. Rushworth SA, Chen X-L, Mackman N, Ogborne RM, O'Connell MA. Lipopolysaccharide-induced heme oxygenase-1 expression in human monocytic cells is mediated via Nrf2 and protein kinase C. Journal of Immunology 2005; 175(7): 4408-15.
236. Park SY, Kim YH, Kim E-K, Ryu EY, Lee SJ. Heme oxygenase-1 signals are involved in preferential inhibition of pro-inflammatory cytokine release by surfactin in cells activated with Porphyromonas gingivalis lipopolysaccharide. Chemico-Biological Interactions 2010; 188(3): 437-45.
237. Oh G-S, Pae H-O, Lee B-S, et al. Hydrogen sulfide inhibits nitric oxide production and nuclear factor-kappaB via heme oxygenase-1 expression in RAW264.7 macrophages stimulated with lipopolysaccharide. Free Radical Biology and Medicine 2006; 41(1): 106-19.
238. Lee SE, Jeong SI, Yang H, et al. Extract of Salvia miltiorrhiza (Danshen) induces Nrf2-mediated heme oxygenase-1 expression as a cytoprotective action in RAW 264.7 macrophages. Journal of Ethnopharmacology 2012; 139(2): 541-8.
239. Iles KE, Dickinson DA, Wigley AF, Welty NE, Blank V, Forman HJ. HNE increases HO-1 through activation of the ERK pathway in pulmonary epithelial cells. Free Radical Biology and Medicine 2005; 39(3): 355-64.
240. Pischke SE, Zhou Z, Song R, et al. Phosphatidylinositol 3-kinase/Akt pathway mediates heme oxygenase-1 regulation by lipopolysaccharide. Cellular and Molecular Biology 2005; 51(5): 461-70.
241. Lee T-S, Chau L-Y. Heme oxygenase-1 mediates the antiinflammatory effect of interleukin-10 in mice. Nature Medicine 2002; 8(3): 240-6.
242. Wu W-T, Chi K-H, Ho F-M, Tsao W-C, Lin W-W. Proteasome inhibitors up-regulate haem oxygenase-1 gene expression: requirement of p38 MAPK (mitogen-activated protein kinase) activation but not of NF-kappaB (nuclear factor kappaB) inhibition. Biochemical Journal 2004; 379(Pt 3): 587.
243. Chen JS, Huang PH, Wang CH, Lin FY, Tsai HY. Nrf-2 mediated heme oxygenase-1 expression, an antioxidant-independent mechanism, contributes to anti-atherogenesis and vascular protective effects Ginkgo biloba. Atherosclerosis 2011; 214(2): 301-9.
244. Jang HJ, Kim YM, Tsoyi K, et al. Ethyl pyruvate induces heme oxygenase-1 through p38 mitogen-activated protein kinase activation by depletion of glutathione in RAW 264.7 cells and improves survival in septic animals. Antioxidants and Redox Signaling 2012; 17(6): 878-89.
245. Kurauchi Y, Hisatsune A, Isohama Y, Mishima S, Katsuki H. Caffeic acid phenethyl ester protects nigral dopaminergic neurons via dual mechanisms involving haem oxygenase-1 and brainderived neurotrophic factor. British Journal of Pharmacology 2012; 166(3): 1151-68.
246. Ogborne R, Rushworth S, Charalambos C, O'Connell M. Haem oxygenase-1: a target for dietary antioxidants. Biochemical Society Transactions 2004; 32(6): 1003-5.
247. Jeon WK, Hong HY, Kim BC. Genipin up-regulates heme oxygenase-1 via PI3-kinase-JNK1/2-Nrf2 signaling pathway to enhance the anti-inflammatory capacity in RAW264. 7 macrophages. Archives of Biochemistry and Biophysics 2011; 512(2): 119-25.
248. Yeligar SM, Machida K, Kalra VK. Ethanol-induced HO-1 and NQO1 are differentially regulated by HIF-1alpha and Nrf2 to attenuate inflammatory cytokine expression. Journal of Biological Chemistry 2010; 285(46): 35359-73.
249. Alam J, Cook JL. Transcriptional regulation of the heme oxygenase-1 gene via the stress response element pathway. Current Pharmaceutical Design 2003; 9(30): 2499-511.
250. Lee PJ, Alam J, Sylvester SL, Inamdar N, Otterbein L, Choi AM. Regulation of heme oxygenase-1 expression in vivo and in vitro in hyperoxic lung injury. American Journal of Respiratory Cell and Molecular Biology 1996; 14(6): 556-68.
251. Camhi SL, Alam J, Wiegand GW, Chin BY, Choi AM. Transcriptional activation of the HO-1 gene by lipopolysaccharide is mediated by 5' distal enhancers: role of reactive oxygen intermediates and AP-1. American Journal of Respiratory Cell and Molecular Biology 1998; 18(2): 226-34.
252. Immenschuh S, Hinke V, Katz N, Kietzmann T. Transcriptional induction of heme oxygenase-1 gene expression by okadaic acid in primary rat hepatocyte cultures. Molecular Pharmacology 2000; 57(3): 610-8.
253. Sassone-Corsi P. Coupling gene expression to cAMP signalling: role of CREB and CREM. International Journal of Biochemistry and Cell Biology 1998; 30(1): 27-38.
254. Waltereit R, Weller M. Signaling from cAMP/PKA to MAPK and synaptic plasticity. Molecular Neurobiology 2003; 27(1): 99-106.
255. Lavrovsky Y, Schwartzman ML, Abraham NG. Novel regulatory sites of the human heme oxygenase-1 promoter region. Biochemical and Biophysical Research Communications 1993; 196(1): 336-41.
256. Wijayanti N, Kietzmann T, Immenschuh S. Heme oxygenase-1 gene activation by the NAD(P)H oxidase inhibitor 4-(2-aminoethyl) benzenesulfonyl fluoride via a protein kinase B, p38-dependent signaling pathway in monocytes. Journal of Biological Chemistry 2005; 280(23): 21820-9.
257. Bauer I, Rensing H, Florax A, et al. Expression pattern and regulation of heme oxygenase-1/heat shock protein 32 in human liver cells. Shock 2003; 20(2): 116-22.
258. Roach JP, Moore EE, Partrick DA, et al. Heme oxygenase-1 induction in macrophages by a hemoglobin-based oxygen carrier reduces endotoxin-stimulated cytokine secretion. Shock 2009; 31(3): 251-7.
259. Pittock ST, Norby SM, Grande JP, et al. MCP-1 is up-regulated in unstressed and stressed HO-1 knockout mice: Pathophysiologic correlates. Kidney International 2005; 68(2): 611-22.
260. Inoue S, Suzuki M, Nagashima Y, et al. Transfer of heme oxygenase 1 cDNA by a replication-deficient adenovirus enhances interleukin 10 production from alveolar macrophages that attenuates lipopolysaccharide-induced acute lung injury in mice. Human Gene Therapy 2001; 12(8): 967-79.
261. Kamimoto M, Mizuno S, Nakamura T. Reciprocal regulation of IL-6 and IL-10 balance by HGF via recruitment of heme oxygenase-1 in macrophages for attenuation of liver injury in a mouse model of endotoxemia. International Journal of Molecular Medicine 2009; 24(2): 161-70.
262. Sierra-Filardi E, Vega MA, Sánchez-Mateos P, Corbí AL, Puig-Kröger A. Heme Oxygenase-1 expression in M-CSF-polarized M2 macrophages contributes to LPS-induced IL-10 release. Immunobiology 2010; 215(9-10): 788-95.
263. Piantadosi CA, Withers CM, Bartz RR, et al. Heme oxygenase-1 couples activation of mitochondrial biogenesis to antiinflammatory cytokine expression. Journal of Biological Chemistry 2011; 286(18): 16374-85.
264. Drechsler Y, Dolganiuc A, Norkina O, et al. Heme oxygenase-1 mediates the anti-inflammatory effects of acute alcohol on IL-10 induction involving p38 MAPK activation in monocytes. Journal of Immunology 2006; 177(4): 2592-600.
265. Chauveau C, Rémy S, Royer PJ, et al. Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression. Blood 2005; 106(5): 1694-702.
266. Tullius SG, Nieminen-Kelhä M, Buelow R, et al. Inhibition of ischemia/reperfusion injury and chronic graft deterioration by a single-donor treatment with cobalt-protoporphyrin for the induction of heme oxygenase-1. Transplantation 2002; 74(5): 591-8.
267. Shen X-D, Ke B, Uchida Y, et al. Native macrophages genetically modified to express heme oxygenase 1 protect rat liver transplants from ischemia/reperfusion injury. Liver Transplantation 2011; 17(2): 201-10.
268. Kämpfer H, Kolb N, Manderscheid M, Wetzler C. Macrophagederived heme-oxygenase-1: expression, regulation, and possible functions in skin repair. Molecular Medicine 2001; 7(7): 488-98.
269. Morse D, Pischke SE, Zhou Z, et al. Suppression of inflammatory cytokine production by carbon monoxide involves the JNK pathway and AP-1. Journal of Biological Chemistry 2003; 278(39): 36993-8.
270. Zhong Y, Liu T, Lai W, Tan Y, Tian D, Guo Z. Heme oxygenase-1-mediated reactive oxygen species reduction is involved in the inhibitory effect of curcumin on lipopolysaccharide-induced monocyte chemoattractant protein-1 production in RAW264.7 macrophages. Molecular Medicine Reports 2013; 7(1): 242-6.
271. Sacerdoti D, Colombrita C, Ghattas MH, et al. Heme oxygenase-1 transduction in endothelial cells causes downregulation of monocyte chemoattractant protein-1 and of genes involved in inflammation and growth. Cellular and Molecular Biology 2005; 51(4): 363-70.
272. Ricchetti GA, Williams LM, Foxwell BMJ. Heme oxygenase 1 expression induced by IL-10 requires STAT-3 and phosphoinositol-3 kinase and is inhibited by lipopolysaccharide. Journal of Leukocyte Biology 2004; 76(3): 719-26.
273. Kirino Y, Takeno M, Murakami S, et al. Tumor necrosis factor α acceleration of inflammatory responses by down-regulating heme oxygenase 1 in human peripheral monocytes. Arthritis and Rheumatism 2007; 56(2): 464-75.
274. Ke B, Shen X-D, Tsuchihashi S-I, et al. Viral interleukin-10 gene transfer prevents liver ischemia-reperfusion injury: Toll-like receptor-4 and heme oxygenase-1 signaling in innate and adaptive immunity. Human Gene Therapy 2007; 18(4): 355-66.
275. Koch N, Jung M, Sabat R, et al. IL-10 protects monocytes and macrophages from complement-mediated lysis. Journal of Leukocyte Biology 2009; 86(1): 155-66.
276. Petit-Bertron A-F, Fitting C, Cavaillon J-M, Adib-Conquy M. Adherence influences monocyte responsiveness to interleukin-10. Journal of Leukocyte Biology 2003; 73(1): 145-54.
277. Mizuno T, Doi Y, Mizoguchi H, et al. Interleukin-34 selectively enhances the neuroprotective effects of microglia to attenuate oligomeric amyloid-β neurotoxicity. American Journal of Pathology 2011; 179(4): 2016-27.
278. Kanakiriya SKR, Croatt AJ, Haggard JJ, et al. Heme: a novel inducer of MCP-1 through HO-dependent and HO-independent mechanisms. American Journal of Physiology Renal Physiology 2003; 284(3): F546-54.
279. Cao J, Sodhi K, Inoue K, et al. Lentiviral-human heme oxygenase targeting endothelium improved vascular function in angiotensin II animal model of hypertension. Human Gene Therapy 2011; 22(3): 271-82.
280. Park JH, Oh S-M, Lim SS, et al. Induction of heme oxygenase-1 mediates the anti-inflammatory effects of the ethanol extract of Rubus coreanus in murine macrophages. Biochemical and Biophysical Research Communications 2006; 351(1): 146-52.
281. Kim B-C, Choi J-W, Hong H-Y, et al. Heme oxygenase-1 mediates the anti-inflammatory effect of mushroom Phellinus linteus in LPSstimulated RAW264.7 macrophages. Journal of Ethnopharmacology 2006; 106(3): 364-71.
282. Oh HM, Kang YJ, Lee YS, et al. Protein kinase G-dependent heme oxygenase-1 induction by Agastache rugosa leaf extract protects RAW264.7 cells from hydrogen peroxide-induced injury. Journal of Ethnopharmacology 2006; 103(2): 229-35.
283. Shyur L-F, Huang C-C, Hsu Y-Y, Cheng Y-W, Yang S-D. A sesquiterpenol extract potently suppresses inflammation in macrophages and mice skin and prevents chronic liver damage in mice through JNK-dependent HO-1 expression. Phytochemistry 2011; 72(4-5): 391-9.
284. Jun MS, Kim HS, Kim YM, et al. Ethanol extract of Prunella vulgaris var. lilacina inhibits HMGB1 release by induction of heme oxygenase-1 in LPS-activated RAW 264.7 cells and CLP-induced septic mice. Phytotherapy Research 2012; 26(4): 605-12.
285. Li B, Lee D-S, Choi H-G, et al. Sauchinone suppresses proinflammatory mediators by inducing heme oxygenase-1 in RAW264.7 macrophages. Biological and Pharmaceutical Bulletin 2011; 34(10): 1566-71.
286. Tsoyi K, Jang HJ, Lee YS, Kim YM, Kim HJ. (+)-Nootkatone and (+)-valencene from rhizomes of Cyperus rotundus increase survival rates in septic mice due to heme oxygenase-1 induction. Journal of Ethnopharmacology 2011; 37(3): 1311-7.
287. Park SY, Park DJ, Kim YH, Kim Y, Choi Y-W, Lee SJ. Schisandra chinensis α-iso-cubebenol induces heme oxygenase-1 expression through PI3K/Akt and Nrf2 signaling and has anti-inflammatory activity in Porphyromonas gingivalis lipopolysaccharide-stimulated macrophages. International Immunopharmacology 2011; 11(11): 1907-15.
288. Lee M-Y, Seo C-S, Lee J-A, et al. Alpinia katsumadai H(AYATA) seed extract inhibit LPS-induced inflammation by induction of heme oxygenase-1 in RAW264.7 cells. Inflammation. 2012;35(2):746-57.
289. Cheng Y-W, Cheah K-P, Lin C-W, et al. Myrrh mediates haem oxygenase-1 expression to suppress the lipopolysaccharide-induced inflammatory response in RAW264.7 macrophages. Journal of Pharmacy and Pharmacology 2011; 63(9): 1211-8.
290. Lee J-A, Lee M-Y, Seo C-S, et al. Asiasari sieboldii suppresses inflammatory mediators through the induction of hemeoxygenase-1 expression in RAW264.7 cells. Immunopharmacology and Immunotoxicology 2012; 34(1): 15-20.
291. Bhaskaran N, Shukla S, Kanwal R, Srivastava JK, Gupta S. Induction of heme oxygenase-1 by chamomile protects murine macrophages against oxidative stress. Life Sciences 2012; 90(25-26): 1027-33.
292. Seo WY, Ju SM, Song HY, et al. Celastrol suppresses IFN-gammainduced ICAM-1 expression and subsequent monocyte adhesiveness via the induction of heme oxygenase-1 in the HaCaT cells. Biochemical and Biophysical Research Communications 2010; 398(1): 140-5.
293. Liby K, Hock T, Yore MM, et al. The synthetic triterpenoids, CDDO and CDDO-imidazolide, are potent inducers of heme oxygenase-1 and Nrf2/ARE signaling. Cancer Research 2005; 65(11): 4789-98.
294. Park H-J, Han ES, Park DK, Lee C, Lee KW. An extract of Phellinus linteus grown on germinated brown rice inhibits inflammation markers in RAW264.7 macrophages by suppressing inflammatory cytokines, chemokines, and mediators and upregulating antioxidant activity. Journal of Medicinal Food 2010; 13(6): 1468-77.
295. Hwa JS, Jin YC, Lee YS, et al. 2-methoxycinnamaldehyde from Cinnamomum cassia reduces rat myocardial ischemia and reperfusion injury in vivo due to HO-1 induction. Journal of Ethnopharmacology 2012; 139(2): 605-15.
296. Ryu EY, Park AJ, Park SY, et al. Inhibitory effects of Ginkgo biloba extract on inflammatory mediator production by Porphyromonas gingivalis lipopolysaccharide in murine macrophages via Nrf-2 mediated heme oxygenase-1 signaling pathways. Inflammation 2012; 35(4): 1477-86.
297. Lee JC, Bhora F, Sun J, et al. Dietary flaxseed enhances antioxidant defenses and is protective in a mouse model of lung ischemia-reperfusion injury. American Journal of Physiology-Lung Cellular and Molecular Physiology 2008; 294(2): L255-65.
298. Jeong S-O, Oh G-S, Ha H-Y, et al. Dimethoxycurcumin, a Synthetic Curcumin Analogue, Induces Heme Oxygenase-1 Expression through Nrf2 Activation in RAW264.7 Macrophages. Journal of Clinical Biochemistry and Nutrition 2009; 44(1): 79-84.
299. Kim AN, Jeon WK, Lee JJ, Kim BC. Up-regulation of heme oxygenase-1 expression through CaMKII-ERK1/2-Nrf2 signaling mediates the anti-inflammatory effect of bisdemethoxycurcumin in LPS-stimulated macrophages. Free Radical Biology and Medicine 2010; 49(3): 323-31.
300. Hsu H-Y, Chu L-C, Hua K-F, Chao LK. Heme oxygenase-1 mediates the anti-inflammatory effect of Curcumin within LPSstimulated human monocytes. Journal of Cellular Physiology 2008; 215(3): 603-12.
301. Slater EE, MacDonald JS. Mechanism of action and biological profile of HMG CoA reductase inhibitors. A new therapeutic alternative. Drugs 1988; 36 Suppl 3: 72-82.
302. Chen J-C, Huang K-C, Lin W-W. HMG-CoA reductase inhibitors upregulate heme oxygenase-1 expression in murine RAW264.7 macrophages via ERK, p38 MAPK and protein kinase G pathways. Cellular Signalling 2006; 18(1): 32-9.
303. Gueler F, Park J-K, Rong S, et al. Statins attenuate ischemiareperfusion injury by inducing heme oxygenase-1 in infiltrating macrophages. American Journal of Pathology 2007; 170(4): 1192-9.
304. Fujita E, Shimizu A, Masuda Y, et al. Statin attenuates experimental anti-glomerular basement membrane glomerulonephritis together with the augmentation of alternatively activated macrophages. American Journal of Pathology 2010; 177(3): 1143-54.
305. Leung P-O, Wang S-H, Lu S-H, Chou W-H, Shiau C-Y, Chou T-C. Simvastatin inhibits pro-inflammatory mediators through induction of heme oxygenase-1 expression in lipopolysaccharide-stimulated RAW264.7 macrophages. Toxicology Letters 2011; 207(2): 159-66.
306. Gill AJ, Kolson DL. Dimethyl Fumarate Modulation of Immune and Antioxidant Responses: Application to HIV Therapy. Critical Reviews in Immunology. 2013; 33(4): 307-59.
307. Nugteren-Huying WM, van der Schroeff JG, Hermans J, Suurmond D. Fumaric acid therapy for psoriasis: a randomized, double-blind, placebo-controlled study. Journal of the American Academy of Dermatology 1990; 22(2 Pt 1): 311-2.
308. Kolbach DN, Nieboer C. Fumaric acid therapy in psoriasis: results and side effects of 2 years of treatment. Journal of the American Academy of Dermatology 1992; 27(5 Pt 1): 769-71.
309. Ghoreschi K, Brück J, Kellerer C, et al. Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells. Journal of Experimental Medicine 2011; 208(11): 2291-303.
310. Devadas K, Dhawan S. Hemin activation ameliorates HIV-1 infection via heme oxygenase-1 induction. Journal of Immunology 2006; 176(7): 4252-7.
311. Zhou ZH, Kumari N, Nekhai S, et al. Heme oxygenase-1 induction alters chemokine regulation and ameliorates human immunodeficiency virus-type-1 infection in lipopolysaccharidestimulated macrophages. Biochemical and Biophysical Research Communications 2013; 435(3): 373-7.
312. Seu L, Burt TD, Witte JS, Martin JN, Deeks SG, McCune JM. Variations in the heme oxygenase-1 microsatellite polymorphism are associated with plasma CD14 and viral load in HIV-infected African-Americans. Genes and Immunity 2011; 13(3): 258-67.